136
Participants
Start Date
August 31, 2014
Primary Completion Date
April 26, 2021
Study Completion Date
April 26, 2021
Clinical Trial Site, New York
Clinical Trial Site, Philadelphia
Clinical Trial Site, Winston-Salem
Clinical Trial Site, Miami
Clinical Trial Site, Ann Arbor
Clinical Trial Site, Galveston
Clinical Trial Site, Salt Lake City
Clinical Trial Site, San Francisco
Clinical Trial Site, Camperdown
Clinical Trial Site, Leuven
Clinical Trial Site, Sofia
Clinical Trial Site, Prague
Clinical Trial Site, Helsinki
Clinical Trial Site, Paris
Clinical Trial Site, Chemnitz
Clinical Trial Site, Petah Tikva
Clinical Trial Site, Milan
Clinical Trial Site, Modena
Clinical Trial Site, Mexico City
Clinical Trial Site, Rotterdam
Clinical Trial Site, Bergen
Clinical Trial Site, Warsaw
Clinical Trial Site, Cape Town
Clinical Trial Site, Seoul
Clinical Trial Site, Barcelona
Clinical Trial Site, Murcia
Clinical Trial Site, Zurich
Clinical Trial Site, Taipei
Clinical Trial Site, Cardiff
Clinical Trial Site, London
Lead Sponsor
Alnylam Pharmaceuticals
INDUSTRY